论文部分内容阅读
目的观察尿激酶在急性心肌梗死中早期静脉溶栓疗效及不良反应。方法对56例急性心肌梗死患者早期给予国产尿激酶150万单位30min静脉应用进行溶栓治疗。结果冠脉血管再通38例,再通率67.8%,无严重不良反应。结论早期急性心肌梗死应用尿激酶进行静脉溶栓疗效好,相对安全,值得在基层医院进一步推广。
Objective To observe the efficacy and adverse reactions of urokinase in early venous thrombolysis in acute myocardial infarction. Methods Fifty-six patients with acute myocardial infarction were given intravenous thrombolytic therapy with 1.5 million units of urokinase for 30 minutes. Results Coronary artery recanalization in 38 cases, the recurrence rate of 67.8%, no serious adverse reactions. Conclusion Early intravenous thrombolytic therapy with Urokinase in acute myocardial infarction is effective and relatively safe, which is worth further promotion in primary hospitals.